Antiemetics Market: Global Industry Analysis and Forecast

Antiemetics Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2032

5.98%

CAGR (2025-2032)

7.76 USD Bn.

Market Size

323

Report Pages

131

Market Tables

Overview

Antiemetics Market was valued at USD 7.76 Bn. in 2024, and total global Antiemetics Market revenue is expected to grow at a CAGR of 5.98% from 2025 to 2032, reaching nearly USD 12.35 Bn. Rising cancer prevalence boosting chemotherapy-induced nausea cases

Antiemetics Market Overview:

Antiemetics are antiemetic medications that help with nausea and vomiting. Motion sickness, dizziness, pregnancy, mental stress, and food poisoning are just a few of the medical problems that cause nausea and vomiting. These treatments are frequently used to address the side effects of other medications such as opioid analgesics, chemotherapy, and general anesthesia. Moreover, antiemetics are also used to revert the venom effect, or sneak bites. Antiemetics Market To know about the Research Methodology :- Request Free Sample Report

Antiemetics Market Dynamics:

Antiemetics Market size was valued at US$ 15.61 Bn. in 2023 and the total revenue is expected to grow at 6.9% through 2024 to 2030, reaching nearly US$ 24.91 Bn.

When a patient is prescribed opioid analgesics, antiemetic medications are used to control nausea and vomiting; this is likely to drive the Antiemetics Market. Antiemetic medications are routinely provided to sedated patients for surgery to combat side effects, which is expected to be another important contributor to the consistent development of revenue. Furthermore, antiemetic medications are used in innovative drugs in clinical trials and new therapies, which might be another driver of market expansion. Detoxification, individuals undergoing alcohol addiction treatment, and food poisoning adverse effects are some of the main market drivers.

Several limits and hurdles will stifle market expansion. During the projected period, challenges such as the lack of a suitable animal model that would match human reactions to antiemetic medication are expected to stifle growth. Furthermore, rising R&D costs, a piece of inadequate knowledge about the wide assortment of antiemetic and antinauseant drugs, and antiemetic drugs in the diagnosis stage that require improvements in clinical trial design for commercial exploitation are all possible future restraints to the global antiemetics market's overall growth. Nevertheless, technological advancements and untapped potential in developing countries present attractive opportunities in the global antiemetics market.

Partnerships, Collaborations, and Acquisitions:

1.Pfizer and BioNTech SE today signed an exclusive partnership agreement with COVAX for up to 40 million doses of the Pfizer-Biotech COVID-19 Vaccine, which is already in effect on January 22, 2021.

2. Pfizer Inc. agreed to acquire Amplyx Pharmaceuticals, Inc., on April 28, 2021, a private equity firm business focused on the discovery of medicines for devastating and chronic diseases that affect people with weakened immune systems. Fosmanogepix (APX001), Amplyx's main drug, is a unique experimental asset in development for the treatment of invasive fungal infections.

3. Pfizer Group announced a mega-contract with Gilead Sciences, Inc. to manufacture and supply Gilead's investigational antiviral redeliver, as one of several peripheral manufacturing organizations promoting initiatives to significantly increase the supply of the experimental treatment for COVID-19, on August 07, 2021. Pfizer will manufacture and supply redeliver for Gilead under the terms of the arrangement, which will be performed at Pfizer's McPherson, Kansas facility.

Antiemetics Market Segment Analysis:

Based on Type, the 5-HT3 receptor antagonists’ segment dominated the Antiemetics Market in 2024. During the projected period, the 5-HT3 receptor antagonist’s category projected to have the biggest market share. The 5-HT3 receptor's most well-known physiological functions are to coordinate emesis and regulate gastrointestinal motility. Currently available 5-HT3 receptor antagonists are used to treat nausea and vomiting caused by chemotherapy, radiotherapy, and anesthesia, as well as irritable bowel syndrome. Pain and drug addiction are two more therapeutic uses that have been investigated. The 5-HT3 receptor is one of several receptors that have a role in mediating nausea and vomiting, and as such, 5-HT3 receptor antagonists demonstrate optimal anti-emetic efficacy when used in combination with other medication types.

Based on Application, The Chemotherapy segment dominated the Antiemetics Market in 2024. During the projection period, the Chemotherapy category projected to have the biggest market share. The reasons that might be ascribed to the daily increase in the number of cancer patients are boosting demand for this category. With the discovery of new, high-efficacy anticancer treatment drugs, the use of chemotherapy in advanced cancer patients has expanded. The global market is bolstered by increased expenditure in anti-cancer drug research and development, as well as increased demand for advanced cancer treatments. The worldwide chemotherapy medications market is also expected to benefit from increased awareness about cancer and its treatment, as well as early detection. The high cost of cancer therapy, on the other hand, acts as a barrier for patients, particularly in developing nations. Unfavorable reimbursement policies for chemotherapy medications are projected to stifle market expansion throughout the projection period in some countries.

Antiemetics Market Regional Insights:

North America is estimated to dominate the growth of the Antiemetics Market.

Due to the inevitable increased prevalence of patients undergoing chemotherapy and the availability of basic hospital infrastructure, North America is likely to dominate the worldwide antiemetic medicines market. In the projected period, the market is expected to expand due to rising acceptance of existing treatments, increased R&D expenditure in the pharmaceutical industry, and government efforts. Moreover, there is a higher prevalence of chemotherapy patients in the patient pool, as well as the availability of basic hospital facilities. Moreover, the high income and purchasing power of the individual, matured consumer base, high-end healthcare infrastructure, advanced technology are likely to boost the growth of the market in the coming future.

The objective of the report is to present a comprehensive analysis of the Antiemetics Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Antiemetics Market dynamics, structure by analyzing the market segments and projecting the Antiemetics Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Antiemetics Market make the report investor’s guide.

Antiemetics Market Scope: Inquire before buying

Antiemetics Market
Report Coverage	Details
Base Year:	2024	Forecast Period:	2025-2032
Historical Data:	2019 to 2024	Market Size in 2024:	USD 7.76 Bn.
Forecast Period 2025 to 2032 CAGR:	5.98%	Market Size in 2032:	USD 12.35 Bn.
Segments Covered:	by Type	5-HT3 Receptor Antagonists NK1 Receptor Antagonists Dopamine Antagonists Antihistamines Anticholinergics Cannabinoids Others
	by Application	Chemotherapy Motion Sickness Postoperative Nausea and Vomiting (PONV) Gastroenteritis Pregnancy-related Nausea and Vomiting Others
	by Distribution Channel	Hospital Pharmacies Retail Pharmacies Online Pharmacies
	by End-User	Hospitals Cancer Treatment Centers Ambulatory Surgical Centers Homecare Settings Clinics

Antiemetics Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Antiemetics Market Key Player

1. Teva Pharmaceutical
2. GlaxoSmithKline
3. Merck
4. Sanofi-Aventis
5. Bristol-Myers Squibb
6. Eli Lilly and Company
7. Pfizer
8. Astellas Pharma
9. Johnson & Johnson
10.Baxter International
11.Novartis AG
12.Abott laboratories
13.Daiichi Sankyo
14.Eisai Co., Ltd.
15.Tesaro
16.Roche

FAQs:

1. What is the Antiemetics Market value in 2024?
Ans: The Antiemetics Market value in 2024 was estimated as 7.76 Bn USD.

2. What is the Antiemetics Market growth?
Ans: The Antiemetics Market is anticipated to grow with a CAGR of 5.98% in the forecast period and is likely to reach USD 12.35 Billion by the end of 2032.

3. Which segment is expected to dominate the Antiemetics Market during the forecast period?
Ans: North America is expected to dominate the global Antiemetics treatment market. Factors such as the existence of important companies, the high prevalence of antiemetic patients in the region, and established healthcare infrastructure are some of the key factors responsible for the market's huge share.

4. Who are the key players in the Antiemetics Market?
Ans: WATSON Pharmaceuticals (Changzhou), Hanson Pharmaceutical, Sandoz, Zhejiang Langhua Pharmaceuticals, Hansoh Pharmaceutical, Aurobindo Pharma, Jubilant Lifesciences, Torrent Pharmaceuticals, Sun Pharmaceutical, Lilly, Dr. Reddy’s Laboratories, Mylan Pharmaceuticals, Apotex Inc., Teva Pharmaceutical are key players of the global antiemetics market.

5. What is the key driving factor for the growth of the Antiemetics Market?
Ans: Key factors that are driving the Antiemetics market growth include an increase in diseases occurrence and growing drug amalgamation and increase research and development activities about available treatment.

1. Antiemetics Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Antiemetics Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2024) 2.3.5. Company Locations 2.4. Leading Antiemetics Market Companies, by market capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Antiemetics Market: Dynamics 3.1. Antiemetics Market Trends by Region 3.1.1. North America Antiemetics Market Trends 3.1.2. Europe Antiemetics Market Trends 3.1.3. Asia Pacific Antiemetics Market Trends 3.1.4. Middle East and Africa Antiemetics Market Trends 3.1.5. South America Antiemetics Market Trends 3.2. Antiemetics Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Antiemetics Market Drivers 3.2.1.2. North America Antiemetics Market Restraints 3.2.1.3. North America Antiemetics Market Opportunities 3.2.1.4. North America Antiemetics Market Challenges 3.2.2. Europe 3.2.2.1. Europe Antiemetics Market Drivers 3.2.2.2. Europe Antiemetics Market Restraints 3.2.2.3. Europe Antiemetics Market Opportunities 3.2.2.4. Europe Antiemetics Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Antiemetics Market Drivers 3.2.3.2. Asia Pacific Antiemetics Market Restraints 3.2.3.3. Asia Pacific Antiemetics Market Opportunities 3.2.3.4. Asia Pacific Antiemetics Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Antiemetics Market Drivers 3.2.4.2. Middle East and Africa Antiemetics Market Restraints 3.2.4.3. Middle East and Africa Antiemetics Market Opportunities 3.2.4.4. Middle East and Africa Antiemetics Market Challenges 3.2.5. South America 3.2.5.1. South America Antiemetics Market Drivers 3.2.5.2. South America Antiemetics Market Restraints 3.2.5.3. South America Antiemetics Market Opportunities 3.2.5.4. South America Antiemetics Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Antiemetics Industry 3.8. Analysis of Government Schemes and Initiatives For Antiemetics Industry 3.9. Antiemetics Market Trade Analysis 3.10. The Global Pandemic Impact on Antiemetics Market 4. Antiemetics Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2024-2032 4.1. Antiemetics Market Size and Forecast, by Type (2024-2032) 4.1.1. 5-HT3 Receptor Antagonists 4.1.2. NK1 Receptor Antagonists 4.1.3. Dopamine Antagonists 4.1.4. Antihistamines 4.1.5. Anticholinergics 4.1.6. Cannabinoids 4.1.7. Others 4.2. Antiemetics Market Size and Forecast, by Application (2024-2032) 4.2.1. Chemotherapy 4.2.2. Motion Sickness 4.2.3. Postoperative Nausea and Vomiting (PONV) 4.2.4. Gastroenteritis 4.2.5. Pregnancy-related Nausea and Vomiting 4.2.6. Others 4.3. Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 4.3.1. Hospital Pharmacies 4.3.2. Retail Pharmacies 4.3.3. Online Pharmacies 4.4. Antiemetics Market Size and Forecast, by End-User (2024-2032) 4.4.1. Hospitals 4.4.2. Cancer Treatment Centers 4.4.3. Ambulatory Surgical Centers 4.4.4. Homecare Settings 4.4.5. Clinics 4.5. Antiemetics Market Size and Forecast, by Region (2024-2032) 4.5.1. North America 4.5.2. Europe 4.5.3. Asia Pacific 4.5.4. Middle East and Africa 4.5.5. South America 5. North America Antiemetics Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 5.1. North America Antiemetics Market Size and Forecast, by Type (2024-2032) 5.1.1. 5-HT3 Receptor Antagonists 5.1.2. NK1 Receptor Antagonists 5.1.3. Dopamine Antagonists 5.1.4. Antihistamines 5.1.5. Anticholinergics 5.1.6. Cannabinoids 5.1.7. Others 5.2. North America Antiemetics Market Size and Forecast, by Application (2024-2032) 5.2.1. Chemotherapy 5.2.2. Motion Sickness 5.2.3. Postoperative Nausea and Vomiting (PONV) 5.2.4. Gastroenteritis 5.2.5. Pregnancy-related Nausea and Vomiting 5.2.6. Others 5.3. North America Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 5.3.1. Hospital Pharmacies 5.3.2. Retail Pharmacies 5.3.3. Online Pharmacies 5.4. North America Antiemetics Market Size and Forecast, by End-User (2024-2032) 5.4.1. Hospitals 5.4.2. Cancer Treatment Centers 5.4.3. Ambulatory Surgical Centers 5.4.4. Homecare Settings 5.4.5. Clinics 5.5. North America Antiemetics Market Size and Forecast, by Country (2024-2032) 5.5.1. United States 5.5.1.1. United States Antiemetics Market Size and Forecast, by Type (2024-2032) 5.5.1.1.1. 5-HT3 Receptor Antagonists 5.5.1.1.2. NK1 Receptor Antagonists 5.5.1.1.3. Dopamine Antagonists 5.5.1.1.4. Antihistamines 5.5.1.1.5. Anticholinergics 5.5.1.1.6. Cannabinoids 5.5.1.1.7. Others 5.5.1.2. United States Antiemetics Market Size and Forecast, by Application (2024-2032) 5.5.1.2.1. Chemotherapy 5.5.1.2.2. Motion Sickness 5.5.1.2.3. Postoperative Nausea and Vomiting (PONV) 5.5.1.2.4. Gastroenteritis 5.5.1.2.5. Pregnancy-related Nausea and Vomiting 5.5.1.2.6. Others 5.5.1.3. United States Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 5.5.1.3.1. Hospital Pharmacies 5.5.1.3.2. Retail Pharmacies 5.5.1.3.3. Online Pharmacies 5.5.1.4. United States Antiemetics Market Size and Forecast, by End-User (2024-2032) 5.5.1.4.1. Hospitals 5.5.1.4.2. Cancer Treatment Centers 5.5.1.4.3. Ambulatory Surgical Centers 5.5.1.4.4. Homecare Settings 5.5.1.4.5. Clinics 5.5.2. Canada 5.5.2.1. Canada Antiemetics Market Size and Forecast, by Type (2024-2032) 5.5.2.1.1. 5-HT3 Receptor Antagonists 5.5.2.1.2. NK1 Receptor Antagonists 5.5.2.1.3. Dopamine Antagonists 5.5.2.1.4. Antihistamines 5.5.2.1.5. Anticholinergics 5.5.2.1.6. Cannabinoids 5.5.2.1.7. Others 5.5.2.2. Canada Antiemetics Market Size and Forecast, by Application (2024-2032) 5.5.2.2.1. Chemotherapy 5.5.2.2.2. Motion Sickness 5.5.2.2.3. Postoperative Nausea and Vomiting (PONV) 5.5.2.2.4. Gastroenteritis 5.5.2.2.5. Pregnancy-related Nausea and Vomiting 5.5.2.2.6. Others 5.5.2.3. Canada Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 5.5.2.3.1. Hospital Pharmacies 5.5.2.3.2. Retail Pharmacies 5.5.2.3.3. Online Pharmacies 5.5.2.4. Canada Antiemetics Market Size and Forecast, by End-User (2024-2032) 5.5.2.4.1. Hospitals 5.5.2.4.2. Cancer Treatment Centers 5.5.2.4.3. Ambulatory Surgical Centers 5.5.2.4.4. Homecare Settings 5.5.2.4.5. Clinics 5.5.3. Mexico 5.5.3.1. Mexico Antiemetics Market Size and Forecast, by Type (2024-2032) 5.5.3.1.1. 5-HT3 Receptor Antagonists 5.5.3.1.2. NK1 Receptor Antagonists 5.5.3.1.3. Dopamine Antagonists 5.5.3.1.4. Antihistamines 5.5.3.1.5. Anticholinergics 5.5.3.1.6. Cannabinoids 5.5.3.1.7. Others 5.5.3.2. Mexico Antiemetics Market Size and Forecast, by Application (2024-2032) 5.5.3.2.1. Chemotherapy 5.5.3.2.2. Motion Sickness 5.5.3.2.3. Postoperative Nausea and Vomiting (PONV) 5.5.3.2.4. Gastroenteritis 5.5.3.2.5. Pregnancy-related Nausea and Vomiting 5.5.3.2.6. Others 5.5.3.3. Mexico Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 5.5.3.3.1. Hospital Pharmacies 5.5.3.3.2. Retail Pharmacies 5.5.3.3.3. Online Pharmacies 5.5.3.4. Mexico Antiemetics Market Size and Forecast, by End-User (2024-2032) 5.5.3.4.1. Hospitals 5.5.3.4.2. Cancer Treatment Centers 5.5.3.4.3. Ambulatory Surgical Centers 5.5.3.4.4. Homecare Settings 5.5.3.4.5. Clinics 6. Europe Antiemetics Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 6.1. Europe Antiemetics Market Size and Forecast, by Type (2024-2032) 6.2. Europe Antiemetics Market Size and Forecast, by Application (2024-2032) 6.3. Europe Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 6.4. Europe Antiemetics Market Size and Forecast, by End-User (2024-2032) 6.5. Europe Antiemetics Market Size and Forecast, by Country (2024-2032) 6.5.1. United Kingdom 6.5.1.1. United Kingdom Antiemetics Market Size and Forecast, by Type (2024-2032) 6.5.1.2. United Kingdom Antiemetics Market Size and Forecast, by Application (2024-2032) 6.5.1.3. United Kingdom Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 6.5.1.4. United Kingdom Antiemetics Market Size and Forecast, by End-User (2024-2032) 6.5.2. France 6.5.2.1. France Antiemetics Market Size and Forecast, by Type (2024-2032) 6.5.2.2. France Antiemetics Market Size and Forecast, by Application (2024-2032) 6.5.2.3. France Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 6.5.2.4. France Antiemetics Market Size and Forecast, by End-User (2024-2032) 6.5.3. Germany 6.5.3.1. Germany Antiemetics Market Size and Forecast, by Type (2024-2032) 6.5.3.2. Germany Antiemetics Market Size and Forecast, by Application (2024-2032) 6.5.3.3. Germany Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 6.5.3.4. Germany Antiemetics Market Size and Forecast, by End-User (2024-2032) 6.5.4. Italy 6.5.4.1. Italy Antiemetics Market Size and Forecast, by Type (2024-2032) 6.5.4.2. Italy Antiemetics Market Size and Forecast, by Application (2024-2032) 6.5.4.3. Italy Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 6.5.4.4. Italy Antiemetics Market Size and Forecast, by End-User (2024-2032) 6.5.5. Spain 6.5.5.1. Spain Antiemetics Market Size and Forecast, by Type (2024-2032) 6.5.5.2. Spain Antiemetics Market Size and Forecast, by Application (2024-2032) 6.5.5.3. Spain Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 6.5.5.4. Spain Antiemetics Market Size and Forecast, by End-User (2024-2032) 6.5.6. Sweden 6.5.6.1. Sweden Antiemetics Market Size and Forecast, by Type (2024-2032) 6.5.6.2. Sweden Antiemetics Market Size and Forecast, by Application (2024-2032) 6.5.6.3. Sweden Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 6.5.6.4. Sweden Antiemetics Market Size and Forecast, by End-User (2024-2032) 6.5.7. Austria 6.5.7.1. Austria Antiemetics Market Size and Forecast, by Type (2024-2032) 6.5.7.2. Austria Antiemetics Market Size and Forecast, by Application (2024-2032) 6.5.7.3. Austria Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 6.5.7.4. Austria Antiemetics Market Size and Forecast, by End-User (2024-2032) 6.5.8. Rest of Europe 6.5.8.1. Rest of Europe Antiemetics Market Size and Forecast, by Type (2024-2032) 6.5.8.2. Rest of Europe Antiemetics Market Size and Forecast, by Application (2024-2032) 6.5.8.3. Rest of Europe Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 6.5.8.4. Rest of Europe Antiemetics Market Size and Forecast, by End-User (2024-2032) 7. Asia Pacific Antiemetics Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 7.1. Asia Pacific Antiemetics Market Size and Forecast, by Type (2024-2032) 7.2. Asia Pacific Antiemetics Market Size and Forecast, by Application (2024-2032) 7.3. Asia Pacific Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 7.4. Asia Pacific Antiemetics Market Size and Forecast, by End-User (2024-2032) 7.5. Asia Pacific Antiemetics Market Size and Forecast, by Country (2024-2032) 7.5.1. China 7.5.1.1. China Antiemetics Market Size and Forecast, by Type (2024-2032) 7.5.1.2. China Antiemetics Market Size and Forecast, by Application (2024-2032) 7.5.1.3. China Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 7.5.1.4. China Antiemetics Market Size and Forecast, by End-User (2024-2032) 7.5.2. S Korea 7.5.2.1. S Korea Antiemetics Market Size and Forecast, by Type (2024-2032) 7.5.2.2. S Korea Antiemetics Market Size and Forecast, by Application (2024-2032) 7.5.2.3. S Korea Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 7.5.2.4. S Korea Antiemetics Market Size and Forecast, by End-User (2024-2032) 7.5.3. Japan 7.5.3.1. Japan Antiemetics Market Size and Forecast, by Type (2024-2032) 7.5.3.2. Japan Antiemetics Market Size and Forecast, by Application (2024-2032) 7.5.3.3. Japan Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 7.5.3.4. Japan Antiemetics Market Size and Forecast, by End-User (2024-2032) 7.5.4. India 7.5.4.1. India Antiemetics Market Size and Forecast, by Type (2024-2032) 7.5.4.2. India Antiemetics Market Size and Forecast, by Application (2024-2032) 7.5.4.3. India Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 7.5.4.4. India Antiemetics Market Size and Forecast, by End-User (2024-2032) 7.5.5. Australia 7.5.5.1. Australia Antiemetics Market Size and Forecast, by Type (2024-2032) 7.5.5.2. Australia Antiemetics Market Size and Forecast, by Application (2024-2032) 7.5.5.3. Australia Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 7.5.5.4. Australia Antiemetics Market Size and Forecast, by End-User (2024-2032) 7.5.6. Indonesia 7.5.6.1. Indonesia Antiemetics Market Size and Forecast, by Type (2024-2032) 7.5.6.2. Indonesia Antiemetics Market Size and Forecast, by Application (2024-2032) 7.5.6.3. Indonesia Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 7.5.6.4. Indonesia Antiemetics Market Size and Forecast, by End-User (2024-2032) 7.5.7. Malaysia 7.5.7.1. Malaysia Antiemetics Market Size and Forecast, by Type (2024-2032) 7.5.7.2. Malaysia Antiemetics Market Size and Forecast, by Application (2024-2032) 7.5.7.3. Malaysia Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 7.5.7.4. Malaysia Antiemetics Market Size and Forecast, by End-User (2024-2032) 7.5.8. Vietnam 7.5.8.1. Vietnam Antiemetics Market Size and Forecast, by Type (2024-2032) 7.5.8.2. Vietnam Antiemetics Market Size and Forecast, by Application (2024-2032) 7.5.8.3. Vietnam Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 7.5.8.4. Vietnam Antiemetics Market Size and Forecast, by End-User (2024-2032) 7.5.9. Taiwan 7.5.9.1. Taiwan Antiemetics Market Size and Forecast, by Type (2024-2032) 7.5.9.2. Taiwan Antiemetics Market Size and Forecast, by Application (2024-2032) 7.5.9.3. Taiwan Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 7.5.9.4. Taiwan Antiemetics Market Size and Forecast, by End-User (2024-2032) 7.5.10. Rest of Asia Pacific 7.5.10.1. Rest of Asia Pacific Antiemetics Market Size and Forecast, by Type (2024-2032) 7.5.10.2. Rest of Asia Pacific Antiemetics Market Size and Forecast, by Application (2024-2032) 7.5.10.3. Rest of Asia Pacific Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 7.5.10.4. Rest of Asia Pacific Antiemetics Market Size and Forecast, by End-User (2024-2032) 8. Middle East and Africa Antiemetics Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 8.1. Middle East and Africa Antiemetics Market Size and Forecast, by Type (2024-2032) 8.2. Middle East and Africa Antiemetics Market Size and Forecast, by Application (2024-2032) 8.3. Middle East and Africa Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 8.4. Middle East and Africa Antiemetics Market Size and Forecast, by End-User (2024-2032) 8.5. Middle East and Africa Antiemetics Market Size and Forecast, by Country (2024-2032) 8.5.1. South Africa 8.5.1.1. South Africa Antiemetics Market Size and Forecast, by Type (2024-2032) 8.5.1.2. South Africa Antiemetics Market Size and Forecast, by Application (2024-2032) 8.5.1.3. South Africa Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 8.5.1.4. South Africa Antiemetics Market Size and Forecast, by End-User (2024-2032) 8.5.2. GCC 8.5.2.1. GCC Antiemetics Market Size and Forecast, by Type (2024-2032) 8.5.2.2. GCC Antiemetics Market Size and Forecast, by Application (2024-2032) 8.5.2.3. GCC Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 8.5.2.4. GCC Antiemetics Market Size and Forecast, by End-User (2024-2032) 8.5.3. Nigeria 8.5.3.1. Nigeria Antiemetics Market Size and Forecast, by Type (2024-2032) 8.5.3.2. Nigeria Antiemetics Market Size and Forecast, by Application (2024-2032) 8.5.3.3. Nigeria Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 8.5.3.4. Nigeria Antiemetics Market Size and Forecast, by End-User (2024-2032) 8.5.4. Rest of ME&A 8.5.4.1. Rest of ME&A Antiemetics Market Size and Forecast, by Type (2024-2032) 8.5.4.2. Rest of ME&A Antiemetics Market Size and Forecast, by Application (2024-2032) 8.5.4.3. Rest of ME&A Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 8.5.4.4. Rest of ME&A Antiemetics Market Size and Forecast, by End-User (2024-2032) 9. South America Antiemetics Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 9.1. South America Antiemetics Market Size and Forecast, by Type (2024-2032) 9.2. South America Antiemetics Market Size and Forecast, by Application (2024-2032) 9.3. South America Antiemetics Market Size and Forecast, by Distribution Channel(2024-2032) 9.4. South America Antiemetics Market Size and Forecast, by End-User (2024-2032) 9.5. South America Antiemetics Market Size and Forecast, by Country (2024-2032) 9.5.1. Brazil 9.5.1.1. Brazil Antiemetics Market Size and Forecast, by Type (2024-2032) 9.5.1.2. Brazil Antiemetics Market Size and Forecast, by Application (2024-2032) 9.5.1.3. Brazil Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 9.5.1.4. Brazil Antiemetics Market Size and Forecast, by End-User (2024-2032) 9.5.2. Argentina 9.5.2.1. Argentina Antiemetics Market Size and Forecast, by Type (2024-2032) 9.5.2.2. Argentina Antiemetics Market Size and Forecast, by Application (2024-2032) 9.5.2.3. Argentina Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 9.5.2.4. Argentina Antiemetics Market Size and Forecast, by End-User (2024-2032) 9.5.3. Rest Of South America 9.5.3.1. Rest Of South America Antiemetics Market Size and Forecast, by Type (2024-2032) 9.5.3.2. Rest Of South America Antiemetics Market Size and Forecast, by Application (2024-2032) 9.5.3.3. Rest Of South America Antiemetics Market Size and Forecast, by Distribution Channel (2024-2032) 9.5.3.4. Rest Of South America Antiemetics Market Size and Forecast, by End-User (2024-2032) 10. Company Profile: Key Players 10.1. Teva Pharmaceutical 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. GlaxoSmithKline 10.3. Merck 10.4. Sanofi-Aventis 10.5. Bristol-Myers Squibb 10.6. Eli Lilly and Company 10.7. Pfizer 10.8. Astellas Pharma 10.9. Johnson & Johnson 10.10. Baxter International 10.11. Novartis AG 10.12. Abott laboratories 10.13. Daiichi Sankyo 10.14. Eisai Co., Ltd. 10.15. Tesaro 10.16. Roche 11. Key Findings 12. Industry Recommendations 13. Antiemetics Market: Research Methodology 14. Terms and Glossary

Antiemetics Market

Choose License Type